Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer - Top-Institutions - MDSpire

Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

  • By

  • Han-bing Xie

  • Bei-bei Zhang

  • Lin Zhao

  • Le Liu

  • Ping-ping Liu

  • Xin Zhang

  • Shi-di Miao

  • Rui-tao Wang

  • Hai-tao Xu

  • November 25, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Colorectal Cancer
    • Surgical Oncology
    • Liver Metastasis

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Colorectal Cancer
    • Hepatobiliary Oncology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Colorectal Surgery
    • Cancer Biomarkers
    • Liver Metastasis

  • #4

    Harbin Medical University Cancer Hospital
    Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang

    Key Differentiators

    • Colorectal Cancer
    • Surgical Oncology
    • Biomarker Research

  • #5

    The Second Affiliated Hospital of Harbin Medical University
    The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang

    Key Differentiators

    • Colorectal Cancer
    • Clinical Oncology
    • Liver Metastasis

Original Source(s)

Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

  • by Han-bing Xie, Bei-bei Zhang, Lin Zhao, Le Liu, Ping-ping Liu, Xin Zhang, Shi-di Miao, Rui-tao Wang, Hai-tao Xu

  • November 25, 2025

Related Content

Reduced Medicaid Retroactive Eligibility and Out-of-Pocket Costs for Patients With Gastrointestinal Cancer

Reply to: Clarifying multimodal inputs and attribution in colorectal cancer survival prediction

Combining Single-Cell and Spatial Transcriptomics Uncovers Glycolytic Diversity and NEK6-Driven Advancement in Colorectal Cancer